Patient Information | Tumor Size(s) Thyroid PTC | Tumor Size MSO | Molecular Thyroid PTC | Molecular MSO | Reference |
---|---|---|---|---|---|
35 y.o. female | 1.7 cm | 8.2 cm* | No BRAF mutation | No BRAF mutation | Capitão et al. (2017) [24] |
62 y.o. female | 0.8Â cm | 7.2Â cm | HRAS Q61R (38% mutant allele freq) | NRAS Q61R (50% mutant allele freq) | Gomes-Lima et al. (2018) [3] |
42 y.o. female | Microcarcinomas, 0.5Â cm, 0.8Â cm | 13.5Â cm* | No BRAF, KRAS, or RET/PTC mutation | No BRAF, KRAS, or RET/PTC mutation | Leong et al. (2013) [25] |
47 y.o. female | 0.7Â cm | 2.7Â cm | KIT V530I No BRAF or RAS mutation | KIT V530I No BRAF or RAS mutation | Ma et al. (2016) [16] |
44 y.o. female | 0.05Â cm | 5Â cm* | No BRAF mutation | No BRAF mutation | Marti et al. (2012) [22] |
55 y.o. female | 1.2Â cm | 1.5Â cm | No BRAF mutation | No BRAF mutation | Middelbeek et al. (2017) [23] |
32 y.o. female | 0.6Â cm | 6.0Â cm | No BRAF, RET/PTC, or TERT mutation | No BRAF, RET/PTC, or TERT mutation | Tzelepis (2019) [21] |
42 y.o. female | 0.3Â cm, 0.15Â cm | 3 subcentimeter foci | BRAF V600E mutation High-risk miRNA expression profile | BRAF V600E mutation High-risk miRNA expression profile, LOH (1p, 3p, 5q, 9p, 17p and 22q) | Present Case |